Bavarian Nordic wins up to $33m to develop J&J Ebola vaccine 16-Sep-2015 By Fiona BARRY Danish biotech Bavarian Nordic has signed a $9m contract from Johnson & Johnson to improve stability of their joint Ebola vaccine. After options and milestone awards, payment could total $33m.